Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Status:
Terminated
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether gemcitabine and pazopanib are effective in
the treatment of inoperable, locally advanced or metastatic biliary tree cancer
(cholangiocarcinoma or gallbladder carcinoma).